FDA Inspection 1304318 — Stephane Leung Wai Sang, MD

Stephane Leung Wai Sang, MD — FEI 3041668878

The FDA completed an inspection of Stephane Leung Wai Sang, MD on February 24, 2026 in Grand Rapids, MI. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Devices.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
February 24, 2026
Fiscal Year
2026
Product Type
Devices
Project Area
Bioresearch Monitoring
Location
Grand Rapids, MI (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
297421 CFR 812.110(b)Investigator non-compliance with agreement/plan/regulations